AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
-19.32%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$353M
AUM Growth
+$353M
(-24%)
Cap. Flow
-$8.33M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
$8.33M |
Sector Composition
| 1 | Healthcare | 85.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $286M | 80.87% | 2,038,920 | – | – |
|
|
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $47.6M | 13.48% | 1,990,000 | – | – |
|
3
ADMA Biologics
ADMA
$4.12B
| $8.62M | 2.44% | 3,608,171 | – | – |
|
|
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
| $5.4M | 1.53% | 2,389,352 | – | – |
|
5
Cidara Therapeutics
CDTX
$1.66B
| $2.4M | 0.68% | 1,021,148 | – | – |
|
|
VRAY
6
DELISTED
ViewRay, Inc.
VRAY
| $2.21M | 0.63% | 363,640 -1,372,348 | -79% | -$8.33M |
|
|
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
| $1.22M | 0.34% | 472,943 | – | – |
|
|
PTX
8
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $88K | 0.02% | 210,000 | – | – |
|